Publication | Closed Access

Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)

Full Donor ChimerismCell TherapyGraft-versus-host DiseaseTransplantationAutoimmune DiseaseXenotransplantationHematologyImmunologyAutoimmunityGraft SurvivalGraft RejectionBlood TransplantationImmunotherapyMedicineCell TransplantationMaximum Benefit